Scalper1 News
Beleaguered specialty drugmaker Valeant Pharmaceuticals International (VRX) was up sharply Tuesday after it made a deal with Walgreens Boots Alliance (WBA) to sell products that it had previously sold through the now-defunct Philidor. It also said it would deliver an across-the-board 10% price cut. The 20-year agreement, which will go into effect early next year, will cover a variety of dermatology and opthalmology products, including Jublia, the Scalper1 News
Scalper1 News